Search & Analyze
Popular Searches
Anthem Biosciences Ltd.
Healthcare₹769.900.27%
24 Jul, 4:01 PM
CMP₹769.90
Mkt Cap₹43.90K Cr
P/E76.23
P/B14.03
ROE21.98%
52W High₹873.25
52W Low₹579.45
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
76.23
P/B Ratio
14.03
EV/EBITDA
45.94
Price/Sales
21.93
Dividend Yield (%)
0.26
EPS (TTM ₹)
10.22
Book Value (₹)
55.55
ROE (%)
21.98
ROCE (%)
29.62
ROA (%)
18.06
EBITDA Margin (%)
38.20
Net Profit Margin (%)
27.11
Debt/Equity
0.02
Current Ratio
3.79
Interest Coverage
117.83
Asset Turnover
0.67
Working Capital/Sales
1.48
Core EBITDA Growth (%)
30.79
P&L
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 12312.55 | 10569.24 | 14193.7 | 18445.53 | 21243.33 |
| Net Sales | 12312.55 | 10569.24 | 14193.7 | 18445.53 | 21243.33 |
| Total Income | 12802.36 | 11419.68 | 14830.69 | 19302.85 | 22801.16 |
| Total Expenditure | 6641.51 | 6340.53 | 9142.7 | 11735.2 | 12903.6 |
| Operating Profit | 6160.85 | 5079.15 | 5687.99 | 7567.65 | 9897.56 |
| Depreciation | 577.56 | 636.96 | 818.24 | 893.71 | 1340.7 |
| Exceptional Items | — | 618.02 | — | — | -243.91 |
| Profit Before Tax | 5461.4 | 4972.98 | 4773.18 | 6568.68 | 8242.4 |
| Tax | 1406.01 | 1121.13 | 1100.08 | 2056.09 | 2324.48 |
| Profit After Tax (PAT) | 4055.39 | 3851.85 | 3673.1 | 4512.59 | 5917.92 |
| EPS (₹) | 7.11 | 6.75 | 6.48 | 8.07 | 10.55 |
| Dividend Payout % | — | — | — | — | 100 |
Balance Sheet
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 87.76 | 1140.97 | 1118.15 | 1118.15 | 1123.43 |
| Reserves | 13462.22 | 16265.71 | 18128.4 | 22637.03 | 28968.41 |
| Shareholders Funds | 13549.98 | 17406.68 | 19246.55 | 24098.64 | 30425.16 |
| Total Debt | 354.91 | 1250.65 | 2325.26 | 1089.55 | 510.68 |
| Total Liabilities | 17259.28 | 21045.49 | 24767.19 | 29486.36 | 36059.69 |
| Total Assets | 17259.28 | 21045.49 | 24767.19 | 29486.36 | 36059.69 |
| Book Value / Share | 1543.9813 | 30.5121 | 34.4257 | 42.4901 | 53.5714 |
| Assets | 17259.28 | 21045.49 | 24767.19 | 29486.36 | 36059.69 |
Cash Flows
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 3329.13 | 3059.87 | 1401.51 | 4183.36 | 8444.87 |
| Investing Activities | -2054.54 | -3760.16 | -2214.59 | -1521.13 | -7016.21 |
| Financing Activities | 1806.77 | 639.73 | -771.81 | -1336 | -399.98 |
| Net Cash Flow | 3081.36 | -60.56 | -1584.89 | 1326.23 | 1028.68 |
ANTHEM
₹769.90
-0.27%